Your institution may have access to this item. Find your institution then sign in to continue.
Title
Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
Authors
Nolte, F.; Höchsmann, B.; Giagounidis, A.; Lübbert, M.; Platzbecker, U.; Haase, D.; Lück, A.; Gattermann, N.; Taupitz, M.; Baier, M.; Leismann, O.; Junkes, A.; Schumann, C.; Hofmann, W.; Schrezenmeier, H.